Metastatic and locally aggressive BCC: Current treatment options

Abstract

Abstract The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.

Keywords

• basal cell carcinoma
• locally aggressive BCC
• metastatic BCC